Home › Immuron Announces Statistically Significant Results of Triple-Action...
 

Keywords :   


Immuron Announces Statistically Significant Results of Triple-Action...

2016-01-12 18:22:08| Agriculture - Topix.net

Australian microbiome biopharmaceutical company Immuron Limited today announced that IMM-529, a first-in-class oral therapeutic, successfully demonstrated prevention of Clostridium difficile infection recurrence in over 77.8% of infected mice. The mouse model developed by Associate Professor Dena Lyras and her team at Monash University was designed to evaluate the effectiveness of IMM-529 when used in conjunction with standard of care antibiotic treatment.

Tags: results significant announces statistically

Category:Agriculture and Forestry

Latest from this category

All news
28.09BIO completes transition of Thr Pro 80% to 85% Active
28.09This Week in Agribusiness, September 28, 2024
28.09This Week in Agribusiness, September 28, 2024
27.09Washington Corner | September 2024
27.09Dont buy em books about the cattle market
27.09New vaccine technology may offer new solution
27.09U.S. pork producers, veterinarians applaud UN antimicrobial mandate decision
27.09Take time now to prepare swine barns for colder weather
Agriculture and Forestry »
28.09Eastern North Pacific Tropical Weather Outlook
28.09Atlantic Tropical Weather Outlook
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Public Advisory Number 5
28.09Summary for Tropical Storm Joyce (AT1/AL112024)
28.09Post-Tropical Cyclone Helene Public Advisory Number 21
28.09Tropical Storm Joyce Forecast Discussion Number 5
28.09Tropical Storm Joyce Wind Speed Probabilities Number 5
More »